Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ulobetasol lotion - Therapeutics Incorporated

Next Previous
Drug Profile

Ulobetasol lotion - Therapeutics Incorporated

Alternative Names: 000-0551; Halobetasol lotion - Therapeutics Incorporated

Latest Information Update: 13 Apr 2016

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Therapeutics Incorporated
  • Class Anti-inflammatories; Antiallergics; Antipsoriatics; Corticosteroids; Skin disorder therapies; Small molecules
  • Mechanism of Action Phospholipase A2 inhibitors; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Plaque psoriasis

Most Recent Events

  • 13 Apr 2016 No recent reports on development identified - Phase-III for Plaque psoriasis in USA (Topical)
  • 01 Mar 2014 Therapeutics Incorporated completes a phase III trial in Plaque psoriasis in USA (NCT01882647)
  • 31 Dec 2013 Therapeutics Incorporated completes a phase III trial for Plaque psoriasis in USA (NCT01871402)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top